These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28275334)

  • 1. Clinical Significance of an Alloantibody against the Kell Blood Group Glycoprotein.
    Mattaloni SM; Arnoni C; Céspedes R; Nonaka C; Trucco Boggione C; Luján Brajovich ME; Trejo A; Zani N; Biondi CS; Castilho L; Cotorruelo CM
    Transfus Med Hemother; 2017 Jan; 44(1):53-57. PubMed ID: 28275334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and functional analyses describe a novel 730delG mutation in the KEL gene causing K0 phenotype in a Taiwanese blood donor.
    Yang MH; Li L; Kuo YF; Hung YS; Yu LC; Hung CS; Tsai SJ; Lin KS; Chu DC
    Transfus Med; 2011 Oct; 21(5):318-24. PubMed ID: 21707797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.
    Kakaiya RM; Whaley A; Howard-Menk C; Rami J; Papari M; Campbell-Lee S; Malecki Z
    Immunohematology; 2010; 26(3):119-23. PubMed ID: 21214298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Identification Idea of Antibodies Against Ku and Other High-Frequency Antigens].
    Zhang FF; Li JW; Shen W; He Y; Yuan H; Tian L; Ye ZJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):875-882. PubMed ID: 38926983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.
    Ji Y; Veldhuisen B; Ligthart P; Haer-Wigman L; Jongerius J; Boujnan M; Ait Soussan A; Luo G; Fu Y; van der Schoot CE; de Haas M
    Transfusion; 2015 Feb; 55(2):413-21. PubMed ID: 25156717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kell and Kx blood group systems.
    Denomme GA
    Immunohematology; 2015; 31(1):14-9. PubMed ID: 26308465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.
    Manoura A; Korakaki E; Hatzidaki E; Saitakis E; Maraka S; Papamastoraki I; Matalliotakis E; Foundouli K; Giannakopoulou C
    Pediatr Hematol Oncol; 2007; 24(1):69-73. PubMed ID: 17130116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
    Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Basis of KELnull Phenotype in Brazilians.
    Boturão-Neto E; Yamamoto M; Chiba AK; Kimura EY; de Oliveira Mdo C; do Monte Barretto CL; Nunes MM; Albuquerque SR; de Deus Santos MD; Bordin JO
    Transfus Med Hemother; 2015 Jan; 42(1):52-8. PubMed ID: 25960716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic disease of the fetus and newborn due to multiple alloantibodies in pregnancy.
    Gupta V; Sidhu M; Shah SN
    Asian J Transfus Sci; 2020; 14(1):83-86. PubMed ID: 33162715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jr
    Ohto H; Denomme GA; Ito S; Ishida A; Nollet KE; Yasuda H
    Transfus Apher Sci; 2020 Oct; 59(5):102949. PubMed ID: 32994126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel alleles in the Kell blood group system resulting in the Knull phenotype and the first in a Native American.
    Moulds JM; Persa R; Rierson D; Billingsley KL; Noumsi GT; Hue-Roye K; Reid ME
    Transfusion; 2013 Nov; 53(11 Suppl 2):2867-71. PubMed ID: 23581548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
    Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
    Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Donation During Pregnancy Due to Anti-Ku Hemolytic Disease of the Fetus and Newborn.
    Virk M; Papakonstantino K; Cai W; Oh D; Andrews J
    Lab Med; 2019 Oct; 50(4):421-425. PubMed ID: 31089725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic disease of the fetus and newborn due to minor blood group alloimmunization in a mother of sickle cell disease with multiple alloantibodies.
    Varghese S; Prakash S; Mukherjee S; Sahu A; Mishra D
    Asian J Transfus Sci; 2023; 17(2):291-294. PubMed ID: 38274971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
    Weiner CP; Widness JA
    Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
    Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
    Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.